The Global Plan to End TB 2023-2030 calls for a global investment of $250 billion.
A study of data from insured US children found that rotavirus vaccination was associated with reduced antibiotic prescribing for acute gastroenteritis, researchers reported last week in Open Forum Infectious Diseases.
Patients with antibiotic-resistant tuberculosis can be treated with a 6-month, all-oral regimen, the agency says.
Also, the elderly, Black Americans, and those with less education were less likely to use free at-home COVID-19 tests.
The new recommendations aim to close a large detection gap in children and teens.
Data show 4 months of antituberculosis treatment non-inferior to the standard 6-month treatment.
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
In a phase 3 trial, an investigational oral microbiome therapy was superior to placebo in reducing the risk of recurrent Clostridioides difficile infection, researchers reported yesterday in the New England Journal of Medicine.
A new report shows that global funding for tuberculosis (TB) research is at less than half the goal set by United Nations (UN) member states, with countries falling far short of funding commitments.
Preliminary data from a phase 3 trial in three countries was released this week at an international conference.
